home / stock / rxd / rxd news


RXD News and Press, ProShares UltraShort Health Care From 05/11/21

Stock Information

Company Name: ProShares UltraShort Health Care
Stock Symbol: RXD
Market: NYSE

Menu

RXD RXD Quote RXD Short RXD News RXD Articles RXD Message Board
Get RXD Alerts

News, Short Squeeze, Breakout and More Instantly...

RXD - ProShares Announces ETF Share Splits

ProShares, a premier provider of ETFs, announced today forward and reverse share splits on twenty-three of its ETFs. The splits will not change the total value of a shareholder’s investment and will be effective on two separate dates. Forward Splits Eight ETFs will fo...

RXD - Building A Healthy Portfolio: Spotlight On Healthcare

Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare

RXD - Telemedicine And Digital Health Are Crossing The Chasm

In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...

RXD - Weekly Market Pulse: Peaking? Already?

Current economic data is certainly strong - although not universally so - but the bond and currency markets may be pointing to some weakness ahead. The copper to gold ratio which peaked in early March, leading bond yields by a full month, has recently resumed its uptrend. The comm...

RXD - Stocks, Bonds And Sector Rotation - Market Update - Have U.S. Treasury Bonds Bottomed?

Since U.S. Treasury bonds have fallen more than -20% in value, it looks like we might've seen a short-term bottom and an opportunity to profit in the bond market. Which sectors are performing well in the intermediate term, as well as those that are taking a breather in the short term....

RXD - Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...

RXD - Diagnosing The Future Of Healthcare

In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if you zoom out into the future, and you look back, and you ask the question, ...

RXD - Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets. LeMaitre Vascular Inc. manufactures and distributes medical devices for the tre...

RXD - A Stock Picker's Guide To 2021

After a dramatic year of volatility, the U.S. stock market ended 2020 at record highs. Can this momentum continue this year? ESG investments clearly outperformed in 2020. 2021 should be a year of much better cash flow for companies. For further details see: A Stock Picke...

RXD - Why We Favor Tech And Healthcare

The pandemic has sped up structural trends that are benefiting sectors such as technology and healthcare - and we believe these trends are not fully priced in. Rising inflation expectations have driven up U.S. 10-year Treasury yields but to a lesser degree than in the past, in line wi...

Previous 10 Next 10